A Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension

Conditions:   Open-Angle Glaucoma;   Ocular Hypertension Interventions:   Drug: Bimatoprost SR;   Drug: LUMIGAN Sponsor:   Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials